Don’t like a paper, but don’t want to retract it? Just issue an “editorial statement”

Last April, the American Journal of Epidemiology and the American Journal of Public Health published a rare joint editorial statement. It concerned a pair of papers on the topic of mortality and obesity. Several complaints had prompted the journals to investigate. Their assessment: These papers contained inaccurate results.

The statement was not a retraction—it was a compromise the editors came up with that would set the academic record straight, while not tainting the authors’ publication record, given that they had (in the editors’ opinion) made honest mistakes. It was an unusual solution to a not-uncommon problem (criticisms of a paper), in which the editors tried to balance their duty to the scientific record against its potential impact on the authors. And it left few people happy — including researchers in the field, who are left unsure about the validity of the results.

Roland Sturm, an economist at Pardee RAND Graduate School who was not a co-author on the papers, told Retraction Watch:

Continue reading Don’t like a paper, but don’t want to retract it? Just issue an “editorial statement”

Caught Our Notice: Forged email for corresponding author dooms diabetes paper

Title: Naringin Alleviates Diabetic Kidney Disease through Inhibiting Oxidative Stress and Inflammatory Reaction

What Caught Our Attention: PLOS ONE had a few reasons for retracting a 2015 paper about a treatment for kidney disease due to diabetes: For one, despite what the paper claims, the authors did not obtain ethical approval to conduct the reported animal experiments. In addition, the corresponding author had no idea the paper had been submitted and published. How could a corresponding author be kept in the dark? It turns out, the journal was given an incorrect email address for him, so he didn’t receive any communications around the paper. (One author apparently used a third party editing company.) Continue reading Caught Our Notice: Forged email for corresponding author dooms diabetes paper

Whoops: Authors didn’t mean to include new data in article about transgender identity

Here’s something we don’t see that often — authors retracting one of their articles because it included new data.

But that is the case with a 2017 review exploring the potential genetic and hormonal underpinnings of gender identity.  The authors Rosa Fernández García and Eduardo Pásaro Mendez told Retraction Watch that they asked bioethics journal Cuadernos de Bioética to withdraw their review after realizing it “indirectly” mentioned some of their unpublished work. According to García, the authors had hoped to publish the new data in a scientific paper before the review came out, but the review ended up being published first.  

Here’s the retraction notice for “Is Sexual Identity Optional? A Study of The Genetics of Transsexuality:”

Continue reading Whoops: Authors didn’t mean to include new data in article about transgender identity

A retraction gets retracted

Last year, an emergency medicine journal retracted a letter to the editor because it didn’t include the author’s potential conflict of interest. Now, it’s had a change of heart.

Earlier this month, the Canadian Journal of Emergency Medicine withdrew the retraction after determining the author, Guy Weinberg, had, in fact, provided information about his potential conflict  with his initial submission. Continue reading A retraction gets retracted

Caught Our Notice: Make love, not fake reviews — semen papers retracted

Titles: 

1) Study of enzyme activities and protein content of beluga (Huso huso) semen before and after cryopreservation

2) Determination of some blood and seminal plasma ions in the beluga, Huso huso (Linnaeus, 1758)

3) Effects of multiple collections on spermatozoa quality of Persian sturgeon, Acipenser persicus: Motility, density and seminal plasma composition

What Caught Our Attention: We won’t lie — any retractions of papers about fish semen (OK, any kind of semen) will make us stop and look. In this case, the journal retracted three papers submitted by the same researcher over concerns of fake review. In the end, the journal was concerned the papers were okayed by reviewers who weren’t “suitably qualified” to review the papers about the content and quality of semen from different fish species. (In fairness, we imagine the pool of qualified reviewers is relatively small.)

Continue reading Caught Our Notice: Make love, not fake reviews — semen papers retracted

Authors retract heart disease paper for “nonscientific reason”

Researchers have retracted a 2018 paper about the genetic underpinnings of heart disease from the FASEB Journal — and it’s not entirely clear why.

The paywalled retraction notice simply cites a “nonscientific reason.” Cody Mooneyhan, the director of publications at the journal, declined to provide further details, and the authors have provided different accounts of what happened: The paper’s corresponding author, John Yu, told Retraction Watch that he requested the retraction because the first author, Chia‐Ti Tsai, refused to sign the journal’s copyright agreement. Tsai, a professor in the Department of Internal Medicine at National Taiwan University in Taipei, told us he was “not notified before the paper was submitted.” Continue reading Authors retract heart disease paper for “nonscientific reason”

An author was accused of faking peer reviews. Turns out he also falsified two images.

In 2015, the journal Cureus published two neurosurgery papers from the same corresponding author, one month apart.

Soon after, the journal uncovered “potential irregularities” with two reviews during a routine editorial audit, editor John R. Adler Jr. told Retraction Watch: Continue reading An author was accused of faking peer reviews. Turns out he also falsified two images.

Caught Our Notice: Researcher who once threatened to sue Retraction Watch now up to 19 retractions

Title: Curcumin-Free Turmeric Exhibits Activity against Human HCT-116 Colon Tumor Xenograft: Comparison with Curcumin and Whole Turmeric

What Caught Our Attention: We haven’t heard much about Bharat Aggarwal since his seven retractions in 2016 propelled him onto our leaderboard (and long after he threatened to sue Retraction Watch for our reporting). There was a whisper of a mention, when his name was listed as one of the organizers of a cancer conference from which MD Anderson (his former employer) had to publicly distance themselves as a co-sponsor. Continue reading Caught Our Notice: Researcher who once threatened to sue Retraction Watch now up to 19 retractions

Caught Our Notice: 54 problems in three scientific images equals one expression of concern

Title: Effects of microRNA-223 on morphine analgesic tolerance by targeting NLRP3 in a rat model of neuropathic pain

What Caught Our Attention: Usually, an Expression of Concern (EOC) offers general language about “concerns regarding the validity of the data” or “concerns regarding the integrity of the study.” Here the language is anything but, saying that 54 Western blot bands within three figures have problems such as “visible pasted joints,” “square border,” and numerous “appear to be the same band.”  According to the notice, the authors have not responded to requests for the original blots, so the editors are allowing the article to remain intact, choosing instead “to alert readers to these issues and allow them to arrive at their own conclusions regarding the figures.” Continue reading Caught Our Notice: 54 problems in three scientific images equals one expression of concern

Authors retract, replace highly cited paper on ADHD in kids

Researchers have retracted and replaced a 2014 paper in JAMA Psychiatry, exploring a new way to classify attention deficit hyperactivity disorder (ADHD) in children, after discovering errors in the data.

Some experts have criticized the current diagnostic criteria for ADHD—noting, in some cases, it could inflate the rate of diagnosis. Sarah L. Karalunas, the paper’s corresponding author, told Retraction Watch that the aim of the study was to look beyond current criteria and “demonstrate an approach that could be used to better delineate the boundaries of ADHD and other psychiatric diagnostic categories.”   Continue reading Authors retract, replace highly cited paper on ADHD in kids